BioLife Solutions reports Q4 EPS ($1.15), consensus (17c)

Reports Q4 revenue $44.3M, consensus $43.28M. CEO Mike Rice commented, "We closed 2022 with another year of strong performance and growth, driven by solid execution across our portfolio…For the full year 2022, we gained over 1,300 new customers via our direct sales team and global network of distributors. Our engineering, quality and operations teams continued to focus on supply chain and other optimization initiatives for our freezers and thaw platform and we expect to continue to drive a mix shift to high margin, recurring revenue." CFO Troy Wichterman remarked, "We achieved full year 2022 positive adjusted EBITDA of $3.6M and ended the year with $64.1M in cash and short-term investments. As of today, Silicon Valley Bank is operational and fully honoring existing credit facilities. We currently have no additional need for capital."